Eledon Pharmaceuticals Inc (ELDN)
Operating Income Growth
7.54%
Quarterly · Period ending:
ELDN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported7.54%period ending
Latest reported7.54%period ending
ELDN Quarterly Operating Income YoY % (-90.91% → 7.54%)
Year-over-year change
High-resolution chart · PNG
ELDN operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 7.5365% | |
| -17.908% | |
| 13.0062% | |
| 7.021% | |
| -70.5489% | |
| -65.2774% | |
| -138.8857% | |
| -83.1577% | |
| -40.0618% | |
| 2.1692% | |
| 82.3848% | |
| -5.6614% | |
| -11.5372% | |
| -12.6889% | |
| -525.3383% | |
| -0.8757% | |
| -16.4597% | |
| -9.4836% | |
| -47.8418% | |
| -70.8848% | |
| -207.6418% | |
| -166.5779% | |
| -52.3398% | |
| -110.5479% | |
| 36.6349% | |
| 30.7077% | |
| 8.9578% | |
| 16.5476% | |
| -28.222% | |
| -74.4186% | |
| -117.4347% | |
| -18.0101% | |
| 52.1602% | |
| -101.8051% | |
| 44.016% | |
| -83.3643% | |
| -615.2361% | |
| 87.9355% | |
| 66.0405% | |
| 86.4198% | |
| 89.6237% | |
| 13.6842% | |
| -76.8408% | |
| -85.3518% | |
| -52.6253% | |
| -171.8724% | |
| -12.8311% | |
| -90.9064% |